| |
|
|
|
Kaleido Biosciences Inc.  
|
|
5.9 -0.23 (-0.04%) |
09-17 16:00 |
|
Open: |
6.06 |
Pre close: |
6.13 |
Target:
|
8.76
|
|
High: |
6.23 |
Low: |
5.661 |
Resistance:
|
7.50
8.92
|
|
Volume: |
106,811 |
Market Cap: |
210M |
Support:
|
5.20
4.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.63
 |
MACD |
MACD(12,26):
|
-0.45 |
|
MA(20): |
6.79  |
Signal(12,26,9): |
-0.32 |
|
MA(100): |
6.89 |
Stochastic Oscillator |
%K(14,3):
|
11.38 |
|
MA(250): |
6.65 |
%D(3): |
6.51 |
|
Average Volume(K) |
3-Month: |
14882
|
52-Week |
High:
|
10.00 |
|
10-Days: |
10808 |
Low: |
2.82 |
|
RSI |
RSI(14):
|
40.31 |
Change(%): |
-38.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.620 |
Return on Equity (ttm) |
-117.6 |
Shares Out. (M) |
35.55 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-49.7 |
Shares Float (M) |
10.55 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.20 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
80.56 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2300 |
|
Book Value (p.s.) |
1.450 |
EBITDA (p.s.) |
-2.160 |
P/E |
-2.24 |
|
Sales Per Share |
0.007 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.06 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-67.09 |
P/S |
836.14 |
|
Operating Margin |
-31314.00 |
Levered Free Cash Flow
(M) |
-44.28 |
P/CF |
-3.12 |
|
|
|
|
|
|
